Phase 3 Study to Evaluate the Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Condition: Pre-Bronchiolitis Obliterans Syndrome Interventions: Drug: ARINA-1; Other: Standard of care only Sponsor: Renovion, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Condition: Pre-Bronchiolitis Obliterans Syndrome Interventions: Drug: ARINA-1; Other: Standard of care only Sponsor: Renovion, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials